Friday, January 28, 2022

South Korean biopharmaceutical firm

Samsung Biologics signs vaccine production deal with Moderna

Under the agreement, the biotech unit of Samsung Group will provide the U.S. drugmaker with contract manufacturing organization (CMO) services for its mRNA vaccine. It means that some of the Moderna vaccine would be produced in South Korea.

Latest News

- Advertisement -